BASEL, Switzerland, Nov. 16, 2023: Versameb AG (“Versameb”), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF […]Read more
If you struggle with bladder leaks during normal daily activities like coughing, sneezing, or during physical activity, you may be a candidate for Bulkamid.
Bulkamid is a minimally invasive and long-lasting treatment option for bladder leaks caused by Stress Urinary Incontinence (SUI).
When given the choice of treatment options for SUI, the majority of women choose Bulkamid.
The Commitment to Collaboration in Continence Care (4Cs) multistakeholder group met in Valencia on 10 November 2023. The meeting objectives were to: a) review progress made in 2023, and b) agree priorities for 2024, aligned with the 4Cs objectives. Discussion focused on maintaining momentum from the 1st EU Continence Health Summit “An Urge to Act”, which was held on 8 November in Brussels, Belgium.Read more
The European Institute for Women’s Health issued its 2024 EU Manifesto for Women’s Health! The document outlines the need for action on women’s health and provides key facts and figures on the current state of play for women in the EU. It describes the key priorities for improving the health and wellbeing of women across the […]Read more
Next year World Continence Week 2024 will, as always, take place in the third week of June, 17-23 June 2024. More details will follow as soon as they are available.Read more
NEWSLETTER | Stay up to date on Health Technology Assessment (HTA) with the EUCAPA’s newsletter Is Health Technology Assessment (HTA) designed with patients in mind? As governments and public institutions assess the impact of new health technology, the patient perspective has to remain the number one priority. Patients, and their advocates, must have access to the […]Read more
In a transformative moment for pharmaceutical regulation within the European Union, the European Patients’ Forum (EPF) calls to redefine what we mean by “unmet medical need.” This critical definition goes beyond the realm of research and development, reaching deep into the core of regulatory data protection, conditional marketing authorisations, and scientific support. Patient organisations represented by EPF are […]Read more
The World Continence Week 2023 toolkit is now available online. Please click here to download the toolkit. For the complete programme of the webinars during World Continence Week 2023, please click here.Read more
WFIPP welcomes our new Corporate Partner Amara Therapeutics. Amara Therapeutics is an Irish-based Digital Therapeutics company who develop app-based treatments for patients suffering from Overactive Bladder (OAB). The company is a spin out from the University of Galway in Ireland and their mission is to make clinically proven, guideline recommended, behavioural therapy available to all […]Read more
Some interested articles/interviews and podcast in the latest newsletter of EAU Edu Platform on Functional Urology (UROLUTS)Read more
This edition of the Best-of-EAU23 is a must-read for those who want to stay ahead of the curve in incontinence healthcare. This newsletter contains a roundup of scientific resources such as webcasts and an EAU TV featurette of riveting case deliberations with a medical lawyer, as well as news coverage of incontinence-focused sessions onsite. You can […]Read more
Antimicrobial Resistance: A Spotlight on Urinary Tract Infections – Is there an issue?
In recent years, there has been a notable increase in antimicrobial resistance and multi-drug resistance among community-acquired uropathogens, predominantly Escherichia coli and Klebsiella pneumoniae, causing urinary tract infections (UTI). The availability of effective oral treatments limited by antimicrobial resistance is of growing concern.
What will you do if you encounter challenging patient cases with unfavourable outcomes? How will you execute clear communication and relay realistic outcome predictions to patients? The Plenary Session: Incontinence nightmares will provide you with vital information on the importance of counselling and patient information when offering surgical treatments. This session will offer expert insights through eye-opening case presentations […]Read more
We would very much appreciate if you could fill in this survey, which will only take 1 to 2 minutes to complete.Read more
After receiving such a variety of high-quality abstract submissions, the 38th Annual EAU Congress in Milan is shaping up to be the largest platform for sharing breaking urology research and innovations in 2023! From the 4,570 abstracts submitted for presentation, 1,304 have been accepted, as well as 127 video abstracts, which makes a total acceptance rate of 31.3%. You can now view the full list of selected abstracts that […]Read more
On the 7th of December 2022 WFIPP took part as one of the partners in the ‘P’-Word Project for a first ever session at the European Parliament in Brussels, hosted by MEP Tomislav SOKOL. The focus of the meeting was how to deal with incontinence issues, not only in relation to prostate and bladder cancer, but […]Read more